Interferon alfa-2b biosimilar (Kee Pharma)

干扰素α-2b生物类似药 (Kee Pharma)

Report date: 2022/01/24 10:09:36

Base Information

Drug NameInterferon alfa-2b biosimilar (Kee Pharma)

Drug Alias Name干扰素α-2b生物仿制药 (Kee Pharma)

ClassificationBiologics > BiosimilarBiologics > Protein drugs > Recombinant protein > Recombinant cytokines

Mechanisms of ActionInterferon alpha/beta receptor agonists

TargetsInterferon alpha/beta receptor

Therapy Area/IndicationsNeoplasmsHepatitis CHepatitis B

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusApproved

Highest Status in ChinaN/A

Originator CompaniesKee Pharma

China Registration ClassN/A

Active CompaniesKee Pharma

Inactive CompaniesN/A

Active IndicationsNeoplasmsHepatitis CHepatitis B

Inactive IndicationsN/A

ATC CodeL03AB05